The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

aeruginosa infection can often receive adequate MSSA coverage with antipseudomonal agents (with the exception of ceftazidime and aztreonam). The intravenous options for MRSA are generally limited ...